4021 logo

Nissan Chemical Corporation Stock Price

TSE:4021 Community·JP¥725.7b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 5 Fair Values set on narratives written by author

4021 Share Price Performance

JP¥0
-4639.00 (-100.00%)
JP¥0
-4639.00 (-100.00%)
Price JP¥0

4021 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Solid track record with excellent balance sheet and pays a dividend.

0 Risks
4 Rewards

Nissan Chemical Corporation Key Details

JP¥263.3b

Revenue

JP¥141.8b

Cost of Revenue

JP¥121.5b

Gross Profit

JP¥76.1b

Other Expenses

JP¥45.3b

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
Feb 09, 2026
337.12
46.14%
17.22%
10.8%
View Full Analysis

About 4021

Founded
1887
Employees
3283
CEO
Kojiro Kinoshita
WebsiteView website
www.nissanchem.co.jp

Nissan Chemical Corporation engages in the chemicals, performance materials, agricultural chemicals, and pharmaceuticals businesses in Japan and internationally. The company provides high purity and custom chemicals; AdBlue, an urea solution; ammonia, sulfuric, and nitric acid, as well as concrete products; TEPIC, an epoxy compound; Melamine Cyanurate, a salt of melamine and iso cyanuric acid; TEPIC-VL, a liquid epoxy compound; Nissan Reishi, a health food; phenylphosphonic acid; HI-LITE, a chlorinated isocyanulate; FINEOXOCOL, a saturated fatty alcohol and acid; HARDBEADS, a spherical fine particles; STARFINE, a Triazine based adhesion; melamine polyphosphate; and NFG, a highly functional additive. It also offers performance materials comprising display, semiconductor, and inorganic materials; agricultural chemicals, such as herbicides, insecticides, fungicides, etc. for use on agricultural land, as well as in golf courses and parks; and drug substances for antiparasite drugs for animals. In addition, the company provides pharmaceutical products, such as LIVALO, a antihypercholesterolemic agent; LANDEL and FINTE, a long-acting calcium channel blocker; and APIs and intermediaries, as well as develops NTC-801, a pharmacological therapeutic agent for treatment of arrhythmia. Further, it develops healthcare, information and communication, and energy materials. The company was formerly known as Nissan Chemical Industries, Ltd. and changed its name to Nissan Chemical Corporation in July 2018. Nissan Chemical Corporation was founded in 1887 and is headquartered in Tokyo, Japan.

Recent 4021 News & Updates

Recent updates

No updates